Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patients-Reference-Cited by-同舟云学术

Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patients

Published:2022-03 Issue: Volume:345 Page:33-38
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Muendlein Axel^ORCID,Brandtner Eva Maria,Leiherer Andreas,Geiger Kathrin,Heinzle Christine,Gaenger Stella,Fraunberger Peter,Mader Arthur,Saely Christoph H.,Drexel Heinz

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. The endothelial glycocalyx: composition, functions, and visualization;Reitsma;Pflügers Arch. - Eur. J. Physiol.,2007

2. Endothelial glycocalyx as biomarker for cardiovascular diseases: mechanistic and clinical implications;Kim;Curr. Heart Fail. Rep.,2017

3. The role of the endothelial glycocalyx in advanced age and cardiovascular disease;Machin;Curr. Opin. Pharmacol.,2019

4. Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine;Ussar;Diabetes,2012

5. Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions;Tumova;Int. J. Biochem. Cell Biol.,2000

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glypican-4 serum levels are associated with cognitive dysfunction and vascular risk factors in Parkinson’s disease;Scientific Reports;2024-02-29

2. Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure;Clinical Biochemistry;2023-11

3. The Shear Stress–Regulated Expression of Glypican-4 in Endothelial Dysfunction In Vitro and Its Clinical Significance in Atherosclerosis;International Journal of Molecular Sciences;2023-07-18

4. Circulating Glypican-4 Is a Predictor of 24-Month Overall Survival in Metastatic Breast Cancer;Oncology Research and Treatment;2023

5. Serum glypican-4 is associated with the 10-year clinical outcome of patients with peripheral artery disease;International Journal of Cardiology;2022-12